0001567619-20-018042.txt : 20201021 0001567619-20-018042.hdr.sgml : 20201021 20201021133228 ACCESSION NUMBER: 0001567619-20-018042 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201021 DATE AS OF CHANGE: 20201021 EFFECTIVENESS DATE: 20201021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InCarda Therapeutics, Inc. CENTRAL INDEX KEY: 0001552622 IRS NUMBER: 264521716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-378475 FILM NUMBER: 201250182 BUSINESS ADDRESS: STREET 1: 39899 BALENTINE DRIVE, SUITE 185 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 408-219-2576 MAIL ADDRESS: STREET 1: 39899 BALENTINE DRIVE, SUITE 185 CITY: NEWARK STATE: CA ZIP: 94560 D 1 primary_doc.xml X0708 D LIVE 0001552622 InCarda Therapeutics, Inc. 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA CALIFORNIA 94560 408-219-2576 DELAWARE None None Corporation true Grace Colon 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA CALIFORNIA 94560 Executive Officer Director Isaac Cheng 39899 BALENTINE, DRIVE, SUITE 185 NEWARK CA CALIFORNIA 94560 Director Alan Colowick 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA CALIFORNIA 94560 Director Johan Christenson 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA CALIFORNIA 94560 Director Andrew ElBardissi 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA CALIFORNIA 94560 Director Dan Welch 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA CALIFORNIA 94560 Director Pharmaceuticals Decline to Disclose 06b false 2020-10-06 false true true false 0 50000000 27993423 22006577 false 5 0 0 0 false InCarda Therapeutics, Inc. /s/ Grace Colon Grace Colon CEO and President 2020-10-20